Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug–Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release
Citations Over TimeTop 10% of 2015 papers
Abstract
Integrating advantages of mitomycin C (MMC)-phospholipid complex for increased drug encapsulation efficiency and reduced premature drug release, DSPE-PEG-folate (DSPE-PEG-FA) for specific tumor targeting, we reported a simple one-pot self-assembly route to prepare the MMC-phospholipid complex-loaded DSPE-PEG-based nanoparticles (MP-PEG-FA NPs). Both confocal imaging and flow cytometry demonstrated that MMC was distributed into nuclei after cellular uptake and intracellular drug delivery. More importantly, the systemically administered MP-PEG-FA NPs led to increased blood persistence and enhanced tumor accumulation in HeLa tumor-bearing nude mice. This study introduces a simple and effective strategy to design the anticancer drug-phospholipid complex-based targeted drug delivery system for sustained/controlled drug release.
Related Papers
- → Lipid Based Vesicular Drug Delivery Systems(2014)179 cited
- → Iron oxide-doped niosomes as drug carriers for magnetically targeted drug delivery(2018)14 cited
- → Nanoparticulate carriers for drug delivery(2022)8 cited
- → Design, synthesis and preliminary biological evaluations of novel amphiphilic drug carriers(2006)11 cited